Coronavirus: Questions about safety of delaying second COVID-19 vaccine dose

About This Source - Global News

Global News is the news and current affairs division of the Canadian Global Television Network, based in Vancouver, Canada.

Recent from Global News:

  • Woman behind 2018 allegation against Gen. Vance tells her story
  • COVID-19: Overwhelmed Ontario hospitals transfer record number of patients
  • Will Derek Chauvin’s conviction be a turning point in the fight for racial justice?
  • Global News published this video item, entitled “Coronavirus: Questions about safety of delaying second COVID-19 vaccine dose” – below is their description.

    There is growing momentum behind the plan to extend the time between the Pfizer-BioNTech and Moderna vaccines.

    British Columbia is stretching that time to four months. The aim is to get at least one dose to more people, giving them partial protection against the novel coronavirus.

    Now other provinces are signalling they could do the same. Abigail Bimman looks at the reason and what difference it could make.

    For more info, please go to https://globalnews.ca/news/7671787/data-coronavirus-vaccine-efficacy/

    Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc

    Like Global News on Facebook HERE: http://bit.ly/255GMJQ

    Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt

    Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB

    #Coronavirus #COVID19 #GlobalNews

    Global News YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • BioNTech’s mRNA vaccine pioneer says third Pfizer dose is likely
  • Can Covid vaccines be mixed? | ITV News
  • U.S. Recommends ‘Pause’ for Johnson & Johnson Vaccine Over Blood Clot Reports
  • J&J Vaccine: Six Cases of Rare Blood Clot Disorder Found in U.S.
  • Lockdown, not vaccines behind drop in UK COVID-19 deaths: Boris Johnson
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • COVID-19: Overwhelmed Ontario hospitals transfer record number of patients
  • On the nose: Perfumers helps COVID patients recover sense of smell
  • Arizona Governor Urges Biden to Declare National Emergency at Southern Border
  • Road to Global Recovery: Insights from ex-governor of China’s central bank
  • Voxpop: Are people still looking forward to 2020 Tokyo Olympics?
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Hotel quarantine transmission concerns, coronavirus vaccines to be made locally | 9 News Australia
  • COVID TRAVEL BUBBLE BUNGLE | Could Australia’s bubble have been burst? | 7NEWS
  • BioNTech’s mRNA vaccine pioneer says third Pfizer dose is likely
  • Victoria announces $50m plan to produce Pfizer, Moderna-style vaccines in Australia | ABC News
  • Coronavirus: Brisbane man suffers blood clot after Pfizer vaccine | 9 News Australia
  • Leave a Comment